Research programme: fagaronine analogues - SIDR

Drug Profile

Research programme: fagaronine analogues - SIDR

Alternative Names: Fagaronine analogues research programme - SIDR; Fagaronine analogues research programme - Strathclyde Institute for Drug Research; Research programme: fagaronine analogues - Strathclyde Institute for Drug Research

Latest Information Update: 05 Feb 2008

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Strathclyde Institute for Drug Research
  • Class Alkaloids; Phenanthridines
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Glioma; Malignant melanoma

Most Recent Events

  • 20 Jul 1999 This programme is available for licensing (
  • 20 Jul 1999 Preclinical development for Glioma in United Kingdom (Unknown route)
  • 20 Jul 1999 Preclinical development for Malignant melanoma in United Kingdom (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top